Literature DB >> 33725861

Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.

Haiyue Dai1, Jun Wang1, Zhongping Shi1, Xiaojun Ji1, Yiwei Huang1, Rui Zhou2.   

Abstract

BACKGROUND: Evidence reveals that microRNA (miRNA) can predict coronary restenosis in patients suffering from coronary heart disease (CHD) after percutaneous coronary intervention (PCI). Perhaps, miRNA-21 is a promising biomarker for the diagnosis of coronary restenosis after PCI. However, the accuracy of miRNA-21 has not been systematically evaluated. Therefore, it is necessary to perform meta-analysis to certify the diagnostic values of miRNA-21 on coronary restenosis after PCI.
METHODS: China National Knowledge Infrastructure, Wanfang, VIP, and China Biology Medicine disc, PubMed, EMBASE, Cochrane Library, and Web of Science were searched for relevant studies to explore the potential diagnostic values of miRNA-21 on coronary restenosis after PCI from inception to January 2021. All data were extracted by 2 experienced researchers independently. The risk of bias about the meta-analysis was confirmed by the Quality Assessment of Diagnostic Accuracy Studies-2. The data extracted were synthesized and heterogeneity was investigated as well. All of the above statistical analyses were carried out with Stata 16.0.
RESULTS: This study proved the pooled diagnostic performance of miRNA-21 on coronary restenosis after PCI.
CONCLUSION: This study clarified confusions about the specificity and sensitivity of miRNA-21 on coronary restenosis after PCI, thus further guiding their promotion and application. ETHICS AND DISSEMINATION: Ethical approval is not required for this study. The systematic review will be published in a peer-reviewed journal, presented at conferences, and shared on social media platforms. This review would be disseminated in a peer-reviewed journal or conference presentations. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/356QK.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33725861      PMCID: PMC7969307          DOI: 10.1097/MD.0000000000024966

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  30 in total

Review 1.  Genetic markers: progress and potential for cardiovascular disease.

Authors:  Gary H Gibbons; Choong Chin Liew; Mark O Goodarzi; Jerome I Rotter; Willa A Hsueh; Helmy M Siragy; Richard Pratt; Victor J Dzau
Journal:  Circulation       Date:  2004-06-29       Impact factor: 29.690

2.  Chinese Herbal Medicines for Restenosis After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Jiaming Wu; Lixian Zhao; Kaixuan Lin; Liming Lu; Chuanjin Luo
Journal:  J Altern Complement Med       Date:  2019-08-29       Impact factor: 2.579

3.  Competing risks and lifetime coronary heart disease incidence during 50years of follow-up.

Authors:  Paolo Emilio Puddu; Paolo Piras; Alessandro Menotti
Journal:  Int J Cardiol       Date:  2016-05-14       Impact factor: 4.164

4.  MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.

Authors:  Ruirui Ji; Yunhui Cheng; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Circ Res       Date:  2007-05-03       Impact factor: 17.367

5.  Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.

Authors:  Maarten J G Leening; Bart S Ferket; Ewout W Steyerberg; Maryam Kavousi; Jaap W Deckers; Daan Nieboer; Jan Heeringa; Marileen L P Portegies; Albert Hofman; M Arfan Ikram; M G Myriam Hunink; Oscar H Franco; Bruno H Stricker; Jacqueline C M Witteman; Jolien W Roos-Hesselink
Journal:  BMJ       Date:  2014-11-17

6.  Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention.

Authors:  Fernando S Montenegro; Marcelo Correia; Fabiana Muccillo; Christina G Souza E Silva; Andrea De Lorenzo
Journal:  BMC Res Notes       Date:  2018-05-08

7.  Coronary heart disease incidence and competing risks: an important issue.

Authors:  Paolo Emilio Puddu; Peter Louis Amaduzzi; Beatrice Ricci
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327

8.  Circulating miRNA-21 as a diagnostic biomarker in elderly patients with type 2 cardiorenal syndrome.

Authors:  Yi Liang; WenJun Zhao; Yan Wang; GuangPing Fu; QingQuan Li; XuChen Min; YiFang Guo
Journal:  Sci Rep       Date:  2020-03-17       Impact factor: 4.379

Review 9.  Meta-Analysis of the Potential Role of miRNA-21 in Cardiovascular System Function Monitoring.

Authors:  Olga Krzywińska; Marietta Bracha; Caroline Jeanniere; Emeline Recchia; Kornelia Kędziora Kornatowska; Mariusz Kozakiewicz
Journal:  Biomed Res Int       Date:  2020-03-31       Impact factor: 3.411

View more
  1 in total

1.  Association of Genetic Variants in miR-217 Gene with Risk of Coronary Artery Disease: A Case-Control Study.

Authors:  Xia Han; Xiaotang Liang; Menghai Wu; Lijun Zhang; Honglei Jiang
Journal:  Pharmgenomics Pers Med       Date:  2021-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.